Digiceuticals Market Segmentation:
Use Segment Analysis
In digiceuticals market, smartphones segment is poised to hold more than 38% share by 2035. The segment growth is on the account of the increasing number of smartphone users in the world. For instance, in 2021, the number of mobile users worldwide stood at 7.1 billion. Smartphone users are increasingly using their phones to get health information, track their data, and plan appointments.
Furthermore, smartphones are rapidly being outfitted with health sensors such as accelerometers, gyroscopes, heart rate monitors, and even pulse oximeters, allowing users to monitor vital indications like heart rate and blood pressure. The segment’s rapid expansion is on the account of these factors.
Application Segment Analysis
In digiceuticals market, diabetes management segment is estimated to capture over 29% revenue share by 2035. The segment growth can be attributed to the increasing prevalence of diabetes, growing awareness about preventive measures, and rising government initiatives to provide better healthcare facilities for diabetic patients. According to IDF projections it is estimated that by 2045 around 783 million adults, which is one in eight individuals will live with diabetes. This represents a 46% increase. It is interesting to note that over 90% of diabetes patients are specifically diagnosed with type 2 diabetes.
Diabetes management requires regular monitoring of blood sugar levels and adjustment of medication accordingly. Digiceuticals allow people with diabetes to track their blood sugar levels remotely and alert them if they need to adjust their medication.
Our in-depth analysis of the digiceuticals market includes the following segments:
|
Use |
|
|
Application |
|
|
Distribution Channel |
|
